Cargando…

The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies

Liver fibrosis results from dysregulation of normal wound healing, inflammation, activation of myofibroblasts, and deposition of extracellular matrix (ECM). Chronic liver injury causes death of hepatocytes and formation of apoptotic bodies, which in turn, release factors that recruit inflammatory ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jun, Liu, Xiao, Koyama, Yukinori, Wang, Ping, Lan, Tian, Kim, In-Gyu, Kim, In H., Ma, Hsiao-Yen, Kisseleva, Tatiana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105921/ https://www.ncbi.nlm.nih.gov/pubmed/25100997 http://dx.doi.org/10.3389/fphar.2014.00167

Ejemplares similares

Strategies to Detect Hepatic Myofibroblasts in Liver Cirrhosis of Different Etiologies
por: Iwaisako, Keiko, et al.
Publicado: (2014)

Inactivation of myofibroblasts during regression of liver fibrosis
por: Kisseleva, Tatiana, et al.
Publicado: (2013)

Promising Therapy Candidates for Liver Fibrosis
por: Wang, Ping, et al.
Publicado: (2016)

The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts
por: Liang, Shuang, et al.
Publicado: (2016)

Origin of myofibroblasts in liver fibrosis
por: Brenner, David A, et al.
Publicado: (2012)

Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation
por: Lan, Tian, et al.
Publicado: (2015)

The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis
por: Fuji, Hiroaki, et al.
Publicado: (2021)

The Origin and Fate of Liver Myofibroblasts
por: Kim, Hyun Young, et al.
Publicado: (2023)

The role of human cytochrome P450 2E1 in liver inflammation and fibrosis
por: Xu, Jun, et al.
Publicado: (2017)

The Role of Butylidenephthalide in Targeting the Microenvironment Which Contributes to Liver Fibrosis Amelioration
por: Chuang, Hong-Meng, et al.
Publicado: (2016)

Combatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis
por: Chen, Li, et al.
Publicado: (2018)

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis
por: Chen, Weimou, et al.
Publicado: (2021)

Cell Signals Influencing Hepatic Fibrosis
por: Cong, Min, et al.
Publicado: (2012)

Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis
por: Bijkerk, Roel, et al.
Publicado: (2019)

Eplerenone Attenuates Fibrosis in the Contralateral Kidney of UUO Rats by Preventing Macrophage-to-Myofibroblast Transition
por: Xiong, Yunzhao, et al.
Publicado: (2021)

Editorial: Fibrosis: etiology, pathophysiology, measurements, and therapy
por: Liu, Yanping, et al.
Publicado: (2023)

Role of macrophage-to-myofibroblast transition in chronic liver injury and liver fibrosis
por: Xia, Suhong, et al.
Publicado: (2023)

Comparison on different traditional Chinese medicine therapies for chronic hepatitis B liver fibrosis
por: Dai, Yun-kai, et al.
Publicado: (2022)

The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis
por: Alhomrani, Majid, et al.
Publicado: (2017)

The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
por: Baglieri, Jacopo, et al.
Publicado: (2019)

Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis
por: Pu, Shiyun, et al.
Publicado: (2021)

Hepatic progenitors for liver disease: current position
por: Conigliaro, Alice, et al.
Publicado: (2010)

Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C
por: Aoudjehane, Lynda, et al.
Publicado: (2015)

Pharmacological Inhibition of STING/TBK1 Signaling Attenuates Myeloid Fibroblast Activation and Macrophage to Myofibroblast Transition in Renal Fibrosis
por: Zeng, Haimei, et al.
Publicado: (2022)

The Dual-Mode Transition of Myofibroblasts Derived from Hepatic Stellate Cells in Liver Fibrosis
por: Yan, Mengchao, et al.
Publicado: (2023)

The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
por: Nishio, Takahiro, et al.
Publicado: (2022)

Polyporus Polysaccharide Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing Myofibroblast Differentiation via TGF-β/Smad2/3 Pathway
por: Jiang, Jintao, et al.
Publicado: (2020)

SNS-032 attenuates liver fibrosis by anti-active hepatic stellate cells via inhibition of cyclin dependent kinase 9
por: He, Xiao-Li, et al.
Publicado: (2022)

New Drugs for Hepatic Fibrosis
por: Shan, Liang, et al.
Publicado: (2022)

The Flavonoid Quercetin Ameliorates Liver Inflammation and Fibrosis by Regulating Hepatic Macrophages Activation and Polarization in Mice
por: Li, Xi, et al.
Publicado: (2018)

Salvia Miltiorrhiza Ameliorates Liver Fibrosis by Activating Hepatic Natural Killer Cells in Vivo and in Vitro
por: Peng, Yuan, et al.
Publicado: (2018)

Disruption of myofibroblastic Notch signaling attenuates liver fibrosis by modulating fibrosis progression and regression
por: Yue, Zhensheng, et al.
Publicado: (2021)

Endothelial Activin Receptor-Like Kinase 1 (ALK1) Regulates Myofibroblast Emergence and Peritubular Capillary Stability in the Early Stages of Kidney Fibrosis
por: Martínez-Salgado, Carlos, et al.
Publicado: (2022)

COVID-19 Infection May Drive EC-like Myofibroblasts towards Myofibroblasts to Contribute to Pulmonary Fibrosis
por: Wu, Xiuju, et al.
Publicado: (2023)

Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
por: Krenkel, Oliver, et al.
Publicado: (2019)

Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?
por: Chan, Yau-Tuen, et al.
Publicado: (2020)

Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling Pathways
por: Li, Zhiyong, et al.
Publicado: (2021)

Ability to Suppress TGF-β-Activated Myofibroblast Differentiation Distinguishes the Anti-pulmonary Fibrosis Efficacy of Two Danshen-Containing Chinese Herbal Medicine Prescriptions
por: Shao, Rui, et al.
Publicado: (2019)

ADAM17 knockdown mitigates while ADAM17 overexpression aggravates cardiac fibrosis and dysfunction via regulating ACE2 shedding and myofibroblast transformation
por: Cheng, Jing, et al.
Publicado: (2022)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ra0ma7o8p3gbbh6r61t3vts0u2